ACR Convergence 2021 Coverage
I

Organ-Specific Issues in Juvenile Systemic Sclerosis

By ACR Convergence 2021 Coverage FEATURING Ivan Foeldvari
By ACR Convergence 2021 Coverage FEATURING Ivan Foeldvari
131 views
November 16, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

39:42
Boehringer Ingelheim

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

Featured Video

18:08
Genentech & Novartis

Shared Voices in the CSU Community

Feat. S. Gawchik

Related Content

AUTOPLAY
22:34
Insights from 2024 ATS Annual Meeting

ATS 2024 Insights: Management Decisions After Early Detection of CTD…

Feat. S. Matson
27:38
Temple Lung Center

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Feat. R. Gupta
51:53
Shaheen Islam

ATS 2022: Approach to Lung Nodules in 2022

16:13
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Post COVID-19 Lung Complications

Feat. M. Padilla
53:31
CHEST 2022 Coverage

Approaching Sarcoidosis Therapy From a 21st Century Perspective

Feat. D. Culver
19:21
CHEST 2022 Coverage

A Radiologist's Approach to Subsolid Pulmonary Nodules

Feat. A. Guttentag
18:13
Bryn Burkholder

Uveitis for the Rheumatologist: How to Define, Recognize and Treat I…

28:18
UCLA Health

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

Feat. J. Belperio
24:02
CHEST 2022 Coverage

Bronchoscopic Imaging for Interstitial Lung Disease

Feat. G. Zhi Cheng
52:53
University of Colorado Department of Medicine

Interstitial Lung Disease in Rheumatic Diseases

Feat. M. Griffith
48:45
UCLA Health

Multidisciplinary ILD Case Discussions

Feat. A. Chung, E. R. Volkmann, F. Abtin, G. Fishbein
21:34
CHEST 2022 Coverage

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Feat. T. Kulkarni
25:48
University of Colorado Department of Medicine

Sarcoidosis: Diagnosis and Management

Feat. N. Held
09:19
Toby Maher

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

34:08
Keck School of Medicine of USC

Medical Marijuana in Rheumatology: Fact or Fiction?

Feat. A. Wells
14:58
Temple Lung Center

The Role of Pulmonary Rehabilitation in ILD

Feat. S. Pourshadid
25:25
Keck School of Medicine of USC

Update on the New ANA Classification System

Feat. E. Taylor-Albert
12:52
The France Foundation

Identifying the Signs and Symptoms of Progressive Pulmonary Fibrosis

Feat. V. Khangoora
16:54
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Lymphangioleiomyomatosis: A Clinical Overview

Feat. F. Mccormack
07:57
Temple Lung Center

Clinical Trials for Pulmonary Fibrotic Diseases

Feat. G. Criner